NEWS
Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers
Credit: Journal of Hepatology Amsterdam, November 14, 2017 - Nonalcoholic fatty liver disease (NAFLD) is one of the more common...
Nano-targeting treatment for prostate cancer
Metastatic or castrate-resistant prostate cancer can spread to the bone in certain patients. While several new treatments are available, they...
Mining for cancer clues
Credit: University of Delaware/ Wenbo Fan Doctors have many weapons in the fight against cancer, but choosing the right one...
Medicaid expansion under ACA linked to higher rate of smoking cessation
PITTSBURGH, Nov. 13, 2017 - When low-income adults were newly covered by Medicaid under the Affordable Care Act (ACA), they...
The first effective therapy against glioblastoma by attacking telomeres
The Telomere and Telomerase Group at the Spanish National Cancer Research Centre (CNIO) has shown that it is possible to...
UC Davis, Leibniz Institute for Photonic Technologies partner in biophotoni
The University of California, Davis, and the Leibniz Institute for Photonic Technologies in Jena, Germany, have entered an agreement of...
Genes that hold the clues to bladder cancer and its treatment
Scientists have discovered the 'genetic signatures' of the most common form of bladder cancer - and it could open up...
Cellular network identified that ‘short circuits’ the antitumor effect of immunotherapies
PHILADELPHIA -- (Nov. 13, 2017) -- Researchers from The Wistar Institute discovered a novel form of crosstalk among tumor cells...
Harder for T cells to fight cancer in absence of VEGF-A
Contrary to what was previously believed, the immune system's cancer-killing T cells are more effective in a tumour's anoxic environment...
Engineering non-immune cells to kill cancer cells
Credit: ETH Zurich T-cells are one of the immune system's major weapons. They detect the body's cells infected with a...
‘Mini liver tumors’ created in a dish for the first time
Scientists have created mini biological models of human primary liver cancers, known as organoids, in the lab for the first...
Ludwig scientists share findings at 2017 Society for Neuro-oncology Annual Meeting
NOVEMBER 13, 2017, NEW YORK - Ludwig Cancer Research has released the scope of its participation at this year's Annual...
ESMO Precision Medicine Glossary published today
LUGANO, Switzerland, 13 November, 2017 - ESMO, the leading professional organisation for medical oncology, is pleased to announce the publication...
PharmaMar presents positive results from a Phase II study of PM1183 in Ewing’s sarcoma
(Pharmamar) PharmaMar (MSE:PHM) has presented positive results from a Phase II study of lurbinectedin in Ewing´s sarcoma at the Connective...
Epigenetic editing reveals surprising insights into early breast cancer development
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain...
Cancer immunotherapy uses melanin against melanoma
Researchers have developed a melanin-enhanced cancer immunotherapy technique that can also serve as a vaccine, based on early experiments done...
Ludwig researchers uncover novel mechanism by which tumors evade cancer immunotherapies
NOVEMBER 10, 2017, New York -- A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig...
Patients with depression and advanced cancer survive longer with palliative care intervention
Credit: Figure by Anna T. Prescott. A new Dartmouth-led study finds that patients with depression and advanced cancer live longer...
Uneven growth in US medical and health R&D investments across sectors
ARLINGTON, Va. -- Nov. 10, 2017 -- Total U.S. investment in medical and health R&D in the U.S. grew by...
Researchers exploit rhythm of DNA replication to kill cancer cells
New DNA is generated in human cells from tiny building blocks called nucleotides produced by an enzyme called RNR. Until...
